Unity Biotechnology (NASDAQ:UBX) Given New $6.00 Price Targe

Unity Biotechnology (NASDAQ:UBX – Get Rating) had its price target upped by Citigroup from $5.00 to $6.00 in a report published on Friday, The Fly reports. Several other equities analysts also recently commented on the company. Wedbush decreased their target price on Unity Biotechnology from $35.00 to $5.00 and set an outperform rating on the […]

Related Keywords

Blackrock , United Kingdom General , United Kingdom , Jan Van Deursen , Judith Campisi , Nathaniel Eames David , Blackrock Inc , Unity Biotechnology Inc , Arete Wealth Advisors , Unity Biotechnology Company Profile , Citigroup , Geode Capital Management , Unity Biotechnology , Get Rating , Wealth Advisors , Street Corp , Capital Management , Sigma Investments , Daohong Zhou , South San Francisco , Unity Biotechnology Daily , Nasdaq Ubx , Subx , Medical , Boost Price Target , Citigroup Inc ,